Abnormal visual contrast acuity in Parkinson's disease

Journal of Parkinson's Disease

Volumn 5, Issue 1, 2015, Pages 125-130

  Lin, Tanya P ^a   Rigby, Heather ^b   Adler, Jennifer S ^c   Hentz, Joseph G ^d   Balcer, Laura J ^e   Galetta, Steven L ^e   Devick, Steve ^f   Cronin, Richard ^f   Adler, Charles H ^d  

^a UNIVERSITY OF ARIZONA COLLEGE OF MEDICINE   (United States)

^b DALHOUSIE UNIVERSITY   (Canada)

^c UNIVERSITY OF ARIZONA   (United States)

^d MAYO CLINIC   (United States)

^e NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

^f King Devick Test   (United States)

Author keywords

contrast sensitivity; Parkinson's disease; vision; visual acuity

Indexed keywords

ABNORMAL VISUAL CONTRAST ACUITY; AGED; ARTICLE; CLINICAL ARTICLE; CONTRAST SENSITIVITY; CONTROLLED STUDY; DEVICES; DISEASE ASSOCIATION; DISEASE SEVERITY; FEMALE; HUMAN; MALE; PARKINSON DISEASE; SCORING SYSTEM; SENSITIVITY ANALYSIS; VISUAL ACUITY; VISUAL ACUITY CHART; VISUAL DISORDER; VISUAL SYSTEM EXAMINATION; COMPLICATION; MIDDLE AGED; PERCEPTUAL DISORDERS; PHOTOSTIMULATION; PHYSIOLOGY; VERY ELDERLY;

AGED; AGED, 80 AND OVER; CONTRAST SENSITIVITY; FEMALE; HUMANS; MALE; MIDDLE AGED; PARKINSON DISEASE; PERCEPTUAL DISORDERS; PHOTIC STIMULATION;

EID: 84923177783     PISSN: 18777171     EISSN: 1877718X     Source Type: Journal    
DOI: 10.3233/JPD-140470     Document Type: Article

References (34)

1. Regan D, & Neima D (1984) Low-contrast letter charts in early diabetic retinopathy, ocular hypertension, glaucoma, and Parkinson's disease. Br J Ophthalmol, 68, 885-889.
2. Nguyen-Legros J (1988) Functional neuroarchitecture of the retina: Hypothesis on the dysfunction of retinal dopaminergic circuitryin Parkinson's disease. Surg Radiol Anat, 10, 137-144.
3. Regan D, & Maxner C (1987) Orientation-selective visual loss in patients with Parkinson's disease. Brain, 110(Pt 2), 415-432.
4. Davidsdottir S, Cronin-Golomb A, & Lee A (2005) Visual and spatial symptoms in Parkinson's disease. Vision Res, 45, 1285-1296.
5. Bulens C, Meerwaldt JD, van der Wildt GJ, & Keemink CJ (1986) Contrast sensitivity in Parkinson's disease. Neurology, 36, 1121-1125.
6. Bodis-Wollner I, Marx MS, Mitra S, Bobak P, Mylin L, & Yahr M (1987) Visual dysfunction in Parkinson's disease. Loss in spatiotemporal contrast sensitivity. Brain, 110(Pt 6), 1675-1698.
7. Diederich NJ, Raman R, Leurgans S, & Goetz CG (2002) Progressive worsening of spatial and chromatic processing deficits in Parkinson disease. Arch Neurol, 59, 1249-1252.
8. Hutton JT, Morris JL, Elias JW, Varma R, & Poston JN (1991) Spatial contrast sensitivity is reduced in bilateral Parkinson's disease. Neurology, 41, 1200-1202.
9. Beach TG, Carew J, Serrano G, Adler CH, Shill HA, Sue LI, Sabbagh MN, Akiyama H, & Cuenca N (2014) Phosphorylated alpha-synuclein-immunoreactive retinal neuronal elements in Parkinson's disease subjects. Neurosci Lett, 571, 34-38.
10. Buttner T, Kuhn W, Muller T, Patzold T, Heidbrink K, & Przuntek H (1995) Distorted color discrimination in 'de novo' parkinsonian patients. Neurology, 45, 386-387.
11. Price MJ, Feldman RG, Adelberg D, & Kayne H (1992) Abnormalities in color vision and contrast sensitivity in Parkinson's disease. Neurology, 42, 887-890.
12. Botha H, & Carr J (2012) Attention and visual dysfunction in Parkinson's disease. Parkinsonism Relat Disord, 18, 742-747.
13. Diederich NJ, Goetz CG, Raman R, Pappert EJ, Leurgans S, & Piery V (1998) Poor visual discrimination and visual hallucinations in Parkinson's disease. Clin Neuropharmacol, 21, 289-295.
14. Shibasaki H, Tsuji S, & Kuroiwa Y (1979) Oculomotor abnormalities in Parkinson's disease. Arch Neurol, 36, 360-364.
15. Uc EY, Rizzo M, Anderson SW, Dastrup E, Sparks JD, & Dawson JD (2009) Driving under low-contrast visibility conditions in Parkinson disease. Neurology, 73, 1103-1110.
16. Moes E, & Lombardi KM (2009) The relationship between contrast sensitivity, gait, and reading speed in Parkinson's disease. Neuropsychol Dev Cogn B Aging Neuropsychol Cogn, 16, 121-132.
17. Uc EY, Rizzo M, Anderson SW, Qian S, Rodnitzky RL, & Dawson JD (2005) Visual dysfunction in Parkinson disease without dementia. Neurology, 65, 1907-1913.
18. Pelli DG, Robson JG, & Wilkins AJ (1988) The design of a new letter chart for measuring contrast sensitivity. Clinical Vision Sciences, 2, 187-199.
19. Regan D, & Neima D (1983) Low-contrast letter charts as a test of visual function. Ophthalmology, 90, 1192-1200.
20. Balcer LJ, Baier ML, Cohen JA, Kooijmans MF, Sandrock AW, Nano-Schiavi ML, Pfohl DC, Mills M, Bowen J, Ford C, Heidenreich FR, Jacobs DA, Markowitz CE, Stuart WH, Ying GS, Galetta SL, Maguire MG, & Cutter GR (2003) Contrast letter acuity as a visual component for the Multiple Sclerosis Functional Composite. Neurology, 61, 1367-1373.
21. Baier ML, Cutter GR, Rudick RA, Miller D, Cohen JA, Weinstock-Guttman B, Mass M, & Balcer LJ (2005) Low-contrast letter acuity testing captures visual dysfunction in patients with multiple sclerosis. Neurology, 64, 992-995.
22. Balcer LJ, Baier ML, Pelak VS, Fox RJ, Shuwairi S, Galetta SL, Cutter GR, & Maguire MG (2000) New low-contrast vision charts: Reliability and test characteristics in patients with multiple sclerosis. Mult Scler, 6, 163-171.
23. Mowry EM, Loguidice MJ, Daniels AB, Jacobs DA, Markowitz CE, Galetta SL, Nano-Schiavi ML, Cutter GR, Maguire MG, & Balcer LJ (2009) Vision related quality of life in multiple sclerosis: Correlation with new measures of low and high contrast letter acuity. J Neurol Neurosurg Psychiatry, 80, 767-772.
24. Jones RD, Donaldson IM, & Timmings PL (1992) Impairment of high-contrast visual acuity in Parkinson's disease. Mov Disord, 7, 232-238.
25. Balcer LJ, Galetta SL, Polman CH, Eggenberger E, Calabresi PA, Zhang A, Scanlon JV, & Hyde R (2012) Low-contrast acuity measures visual improvement in phase 3 trial of natalizumab in relapsing MS. J Neurol Sci, 318, 119-124.
26. Bulens C, Meerwaldt JD, Van der Wildt GJ, & Van Deursen JB (1987) Effect of levodopa treatment on contrast sensitivity in Parkinson's disease. Ann Neurol, 22, 365-369.
27. Hutton JT, Morris JL, & Elias JW (1993) Levodopa improves spatial contrast sensitivity in Parkinson's disease. Arch Neurol, 50, 721-724.
28. Mestre D, Blin O, Serratrice G, & Pailhous J (1990) Spatiotemporal contrast sensitivity differs in normal aging and Parkinson's disease. Neurology, 40, 1710-1714.
29. Owsley C, Ball K, McGwin G Jr, Sloane ME, Roenker DL, White MF, & Overley ET (1998) Visual processing impairment and risk of motor vehicle crash among older adults. JAMA, 279, 1083-1088.
30. Marron JA, & Bailey IL (1982)Visual factors and orientation-mobility performance. Am J Optom Physiol Opt, 59, 413-426.
31. Lord SR (2006) Visual risk factors for falls in older people. Age Ageing, 35(Suppl 2), ii42-ii45.
32. Whittaker SG, & Lovie-Kitchin J (1993) Visual requirements for reading. Optom Vis Sci, 70, 54-65.
33. Scott IU, Feuer WJ, & Jacko JA (2002) Impact of visual function on computer task accuracy and reaction time in a cohort of patients with age-related macular degeneration. Am J Ophthalmol, 133, 350-357.
34. Haymes SA, Johnston AW, & Heyes AD (2002) Relationship between vision impairment and ability to perform activities of daily living. Ophthalmic Physiol Opt, 22, 79-91.